Abstract:Poly(lactic-co-glycolic acid) (PLGA) has garnered increasing attention as a candidate drug delivery polymer owing to its favorable properties, including its excellent biocompatibility, biodegradability, non-toxicity, non-immunogenicity, and mechanical strength. PLAG are specifically used as microspheres for the sustained/controlled and targeted delivery of hydrophilic or hydrophobic drugs, as well as biological therapeutic macromolecules, including peptide and protein drugs. PLGAs with different molecular weights, lactic acid (LA)/glycolic acid (GA) ratios, and end groups exhibit unique release characteristics, which is beneficial for obtaining diverse therapeutic effects. This review aims to analyze the composition of PLGA microspheres, and understand the manufacturing process involved in their production, from a quality by design perspective. Additionally, the key factors affecting PLGA microsphere development are explored as well as the principles involved in the synthesis and degradation of PLGA and its interaction with active drugs. Further, the effects elicited by microcosmic conditions on PLGA macroscopic properties, are analyzed. These conditions include variations in the organic phase (organic solvent, PLGA, and drug concentration), continuous phase (emulsifying ability), emulsifying stage (organic phase and continuous phase interaction, homogenization parameters), and solidification process (relationship between solvent volatilization rate and curing conditions). The challenges in achieving consistency between batches during manufacturing are addressed, and continuous production is discussed as a potential solution. Finally, potential critical quality attributes are introduced, which may facilitate the optimization of process parameters.

PLGA-based biodegradable microspheres in drug delivery: recent advances in research and application

Decoration and Application of PLGA Microspheres

Recent Applications of PLGA in Drug Delivery Systems

PLGA-based drug delivery system for combined therapy of cancer: research progress

Research Ardvance in PLGA Microspheres

Latest Research Progress of Drug Stability and Release of PLGA Microspheres

Poly(lactic-co-glycolic acid) microsphere production based on quality by design: a review

Research Progress on the Application of Porous PLGA Microspheres

The drug release of PLGA-based nanoparticles and their application in treatment of gastrointestinal cancers

Bridging the gap between fundamental research and product development of long acting injectable PLGA microspheres

Research and Application of Biodegradable Polymer Containing Poly(lactic acid) in Preparation of Drug Loaded Microspheres or Microcapsules

The recent insight in the release of anticancer drug loaded into PLGA microspheres

Poly(Lactic Acid)-Based Microparticles for Drug Delivery Applications: An Overview of Recent Advances

Progress in Research and Application of Plga Embolic Microspheres

PLGA sustained-release microspheres loaded with an insoluble small-molecule drug: microfluidic-based preparation, optimization, characterization, and evaluation in vitro and in vivo

Recent Advances in the Preparation Progress of Protein/peptide Drug Loaded PLA/PLGA Microspheres.

Current Advances in Research and Clinical Applications of PLGA-based Nanotechnology

Application of Poly(lactic-co-glycolic acid) Microparticles as Anti-ancer Drug Delivery Vector

Microfluidic‐Generated Biopolymer Microparticles as Cargo Delivery Systems

Current advances in research and clinical applications of PLGA-based nanotechnology.

Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives